Toth, Allison J.
Robert, Stephanie M.
Fahy, Tara
Wang, Seamus Y.
Wierzbicki, Matthew
Bowden, Stephen G.
Budhu, Joshua A.
Pike, Luke R. G.
Smithy, James W.
Imber, Brandon S.
Young, Robert J.
Moss, Nelson S. https://orcid.org/0000-0002-0930-1681
Article History
Received: 11 July 2025
Accepted: 17 September 2025
First Online: 11 November 2025
Declarations
:
: The institutional review board (IRB #16-1531) granted this study a waiver of consent.
: SMR, AJT, TF, SYW, MW, SGB, JAB, LRP, JWS declare that they have no financial interest. B.S.I reports research grants (to institution) from Novartis, Kazia Therapeutics, GT Medical Technologies, AstraZeneca, and Bayer outside the submitted work and serves as a consultant to GT Medical Technologies. R.J.Y consults for Agios, Puma, NordicNeuroLab, Icon, and has a grant funding from Agios. N.S.M has research funding (to institution) from AstraZeneca, Amgen, GT Medical Technologies, and consult for Daiichi Sankyo, Kendle Healthcare, and GLG.
: The authors declare no competing interests.